Company ProfilePremium

Aekyung Industrial Co., Ltd.

Company Profile Analysis

Ticker: 018250.KS애경산업 주식회사

ESOMAR 23 Corporate BadgeISO Certifications Badge
Aekyung Industrial Co., Ltd. - Company showcase

Year Founded & Workforce

1954

932 Employees

Aekyung Industrial Co., Ltd. logo

Aekyung Industrial Co., Ltd. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Aekyung Industrial Co., Ltd. Overview

Aekyung Industrial is a mid-sized Korean "life-beauty" consumer-goods company. It combines a mass household and personal-care franchise with a smaller, more volatile cosmetics business. Its household brands include 2080, Kerasys, Spark, Trio, Shower Mate, Luvscent, Labsin and Liq. The cosmetics business is anchored by AGE20's and LUNA, plus the newer signiq and ONE THING skincare lines. Household goods supply roughly two-thirds of revenue and most of the stable cash generation. Cosmetics has historically supplied most of the profit upside, with heavy dependence on China.

After a weak FY2025 (revenue −3.6%, operating profit −54.8%), Taekwang Industrial acquired the company in March 2026 as its entry point into K-beauty. The new owner has stated a target of raising cosmetics to at least 50% of revenue by 2028, up from about 32% in FY2025. Management is pursuing a revenue-first strategy: rebalancing away from China toward the US, Japan and Europe, and spending heavily on marketing. As a result, margins sit near breakeven and the investment case depends largely on execution.


What the company does

Aekyung Industrial develops, manufactures, markets and distributes two broad product families.

Household goods (생활용품): personal care (hair care, body care, oral care), fabric care (powder and liquid laundry detergents, fabric softeners, neutral detergents), kitchen care (dishwashing detergents), hygiene products and home-care items.

Cosmetics (화장품): base makeup (cushion and "essence cover pact" compacts), colour cosmetics, cleansing products and, increasingly, skincare.

The company's FY2021 business report describes it as two operating segments. The cosmetics segment runs basic and colour cosmetics centred on AGE20's and LUNA. The household goods segment covers detergents, soaps, quasi-drugs (including toothpaste) and personal-care items [S39]. Its registered business purposes also include cosmetics manufacturing, wholesale/retail and import/export of chemical products, household goods, beverages, food and general merchandise [S39].

Business and revenue model

Revenue model: Almost entirely product sales (B2C brands sold through B2B retail channels and the company's own and third-party e-commerce). There is no material subscription, service or licensing income in the sources reviewed. A small "other" line appears in segment reporting: about KRW 11 bn in FY2025 (derived) [S5].

Manufacturing model: Hybrid. The company runs its own plants. Its Daejeon plant held powder-detergent capacity of 82,725 tonnes in the FY2021 business report [S39]. It also uses OEM/ODM suppliers. This includes Chinese contract manufacturer Domy (Zhongshan) Chemical, which made six imported 2080 toothpaste SKUs recalled in January 2026 [S21][S22].

Value-chain position: Branded consumer-goods owner. It sits between raw-material and packaging suppliers (and contract manufacturers) and retail channels: hypermarkets, convenience stores, H&B stores such as Olive Young, Daiso, TV home shopping, duty-free, e-commerce marketplaces (Coupang, Naver, Amazon, Tmall, Douyin, TikTok Shop, Qoo10) and overseas distributors.

Customer types: Mass-market consumers reached through domestic retailers, home shopping, H&B chains and online platforms. Overseas buyers include distributors and retailers such as Walmart (US), Olive Young USA, Rossmann (Poland) and Matsumoto Kiyoshi (Japan) [S13][S14][S35].

End-markets: Korean household and personal care (mature, low growth); Chinese masstige cosmetics (historically the largest export market); and Japanese, US, European, Russian/CIS and Central Asian personal care and cosmetics (current growth vectors) [S5][S14].

Company self-description versus independent characterisation

Company framing: Before 2026 the company described itself as a "life-beauty company" (생활뷰티기업) [S12]. Since joining the Taekwang group it calls itself a "global total beauty company" (글로벌 토탈 뷰티 기업). It has stated an ambition to become a leading total-beauty company representing K-beauty [S19][S20]. Its stated operating strategy has four pillars [S11][S13]:

  • premium-based profitability

  • globalisation

  • responsiveness to growth channel platforms

  • brand-portfolio diversification

Independent characterisation:

Profit structure is inverted relative to the revenue mix: Household goods are about 65% of revenue but earn low single-digit margins. Cosmetics earned double-digit margins in good years (14.5% in FY2023, derived) but collapsed to 3.4% in FY2025 [S5].

  • Cosmetics has long been a single-brand, single-product, single-market business. It has relied on AGE20's Essence Cover Pact and on China. At IPO, more than 85% of cosmetics revenue came from AGE20's [S38]. In 2019 the brand was reported at about 90% of segment results [S50]. China still accounts for more than 80% of overseas revenue as of October 2026 [S5].

The company is now in a deliberate investment phase: Under new ownership, Hana Securities notes that marketing is being raised across every region and category simultaneously. It also notes that mix is shifting toward low-margin household goods. Together these compress margins in the near term [S5].

Strategy

Stated strategy

Pre-acquisition (2024–2025): The company's stated priorities were [S11][S13]:

  • premium-based profitability

  • globalisation

  • responsiveness to growth channels and platforms

  • brand-portfolio diversification (added in 2026)

Management also said it would keep investing domestically and abroad, and launch global-exclusive cosmetics and household products [S9].

Post-acquisition vision (March 2026 AGM) [S18][S19][S20]:

Beauty mix: Raise cosmetics to at least 50% of revenue by 2028, from about 32% in FY2025.

Skincare pivot: Re-weight the portfolio from colour cosmetics toward skincare, led by signiq and ONE THING, while running AGE20's and LUNA as a parallel makeup track.

Household efficiency: Focus household goods (about 60% of revenue) on upgrading hero brands such as Kerasys and Shower Mate.

"Country rebalancing": Reduce China dependence and expand in the US and Europe.

Organisation: Split the business into Makeup, Skincare, Personal Beauty and Home/Dental Care, and create a digital-marketing organisation.

Synergies: Explore cooperation with Taekwang's data home-shopping channel, Shopping NT.

Mega-brands: Grow Kerasys, Shower Mate and Luvscent into global mega-brands and expand global retail distribution [S13].

Acquirer's stated rationale: Taekwang Industrial CEO Yoo Tae-ho told shareholders the deal was not a pure financial investment. He described it as a starting point for entering K-beauty and a base for business expansion through continued investment [S49]. Taekwang has said it plans to invest trillions of won across cosmetics, energy and real-estate development [S32].

Initiatives in the last 24 months (Oct 2024 – Oct 2026)

InitiativeDateDetailSource
AGE20's US launch with Silicon2Apr 2024 onwardAmazon US and Silicon2's MOIDA store; US-tailored shades; sun-care launch[S36]
China MCN partnership (Xinxuan Group)Mar 2025Live-commerce push in China[S31]
Daiso and Olive Young channel expansion2,025Two Edit launch for Daiso; new SKUs across H&B channels[S10][S43]
signiq global skincare brandSep 2025Amazon US, later TikTok Shop, Tmall and Douyin[S37][S13]
Luvscent and Shower Mate at Walmart US; Kerasys at Walmart2025–Mar 2026Kerasys: about 390 stores in 35 states plus online[S35]
Local-sourcing partnership with OttogiJan 2026Cooperation on regional production base and raw-material use (details not disclosed)[S58]
Absorption of ONE THINGApr–Jun 2026Skincare division created; brand rebuilt around the centella line[S24][S25]
New channels in Poland and JapanQ1 2026Rossmann (Poland), Matsumoto Kiyoshi (Japan)[S13]
Olive Young USA listingQ2 2026AGE20's and LUNA[S14]
K-pop marketing in Brazil, Kazakhstan, Uzbekistan2,026Consumer-awareness campaigns[S14][S60]
Trade shows (e.g. Cosmoprof Las Vegas 2026)2025–2026AGE20's ranked first in makeup at Cosmoprof 2025[S11b][S14]
Labour agreementJun 20262026 wage deal signed without dispute; HQ and corporate name retained[S34]

ESG and sustainability commitments

Sustainability reports have been published since 2022, covering FY2021 onward [S39b]. A mono-material packaging collaboration with SK Geo Centric was reported [S60b]. No quantified emissions targets were found.

Cost programmes

No formal cost programme with targets was disclosed. Management's posture is the opposite: marketing intensity is being raised.

Medium-term financial targets and guidance

Explicit target: cosmetics ≥50% of revenue by 2028 [S19].

Q4 2026 internal goal: quarterly revenue of KRW 200 bn in the peak season [S5].

2027 intent: pursue revenue growth and margin improvement together [S5].

  • No formal revenue or EPS guidance has been published.

Historical precedent: The 2018 IPO targets of KRW 1 trillion revenue and a 15% operating margin by 2020 were missed by a wide margin. FY2020 revenue was KRW 588.1 bn with a 3.8% operating margin [S38][S50].

Products & Services

Pricing models are not publicly disclosed for any brand; all products are sold at retail list prices through channels.

Cosmetics segment

BrandDescription and positioningFlagship / recent productsTarget customerLaunch / latestSource
AGE20's (에이지투웨니스)Core base-makeup brand built on the "Essence Cover Pact". The company says its "Essence Pocket" technology holds about 71% moisture essence inside a solid foundation. US shade range expanded from 6 to 11. About 53 SKUs in 2026.Signature Essence Cover Pact; Signature Master Advanced Essence Pact; Velvet Lasting Pact; Super Ectoin Prime Foundation Pact (2025); MelaDefense spot sun care (2026)Women in their 20s–40s; China (Tmall/Douyin/TikTok live), Korea home shopping and H&B, Japan (Qoo10), US (Amazon, Olive Young USA), Poland (2026)Launched 2012; new SKUs annually[S38][S9][S12][S14][S59][S60]
LUNA (루나)Makeup-specialist colour brand; Japan is the lead overseas market. About 23 SKUs. Expanding into Russia, the UK and the US.Long Lasting Tip Concealer; Glassy Layer Tint; Lip & Cheek (2026)Women in their 20s–30s; Japan variety and drug stores, Qoo10, Amazon US, Olive Young USA2026 SKUs added[S9][S12][S14][S60]
POINT (포인트)Cleansing-specialist brandMascara Cleanser; Pack Cleanser (2026)Mass H&B / Daiso shoppersListed among cosmetics brands at IPO (2018); 2026 launches[S38][S14]
signiq (시그닉)The company's first skincare brand designed for global (US) consumers. "Skin signal care" concept; name combines "signal" and "clinic".Plumping Peptide line (4 products, with ginger peptide and deep-liposome technology); 3 eye creams (2026)US consumers aged 25–35; also Amazon US, TikTok Shop, Tmall, DouyinSep 2025[S37][S13][S14][S52]
ONE THING (원씽)Minimalist, single-key-ingredient skincare; acquired in 2022 and absorbed in June 2026. Being repositioned as a global minimalist skincare brand around its centella (병풀) line. FY2025 standalone revenue about KRW 7.2 bn with a net loss of about KRW 3.0 bn.Centella line (cleansers, creams); Jojoba Deep Moisture CreamGlobal skincare consumersAcquired May 2022; merged Jun 2026[S24][S25][S14]
Two Edit (투에딧)Daiso-channel cosmetics brand—Value-channel consumers2,025[S43]
Legacy / discontinuedBonkyeol (본결, launched around 2020); Flow (2018 basic skincare); Sosopul (2019, withdrawn early)———[S50][S56b]

Household goods segment

CategoryBrands (as disclosed)NotesSource
Hair careKerasys (케라시스); Salon de Magie (살롱드마지); Dongui Hongsam (동의홍삼)Kerasys is the premium hair-care flagship. The Propolis Hair Bonding / Pro-Repair line for heavily damaged hair (shampoo, treatment conditioner, leave-in spray) entered Walmart US in March 2026. Tmall flagship opened in 2020. K-pop marketing in Kazakhstan and Uzbekistan.[S35][S14][S50][S39]
Body careShower Mate (샤워메이트); Luvscent (럽센트); Black Fore (블랙포레); Bicolor (바이컬러); Vaseline (listed in the company's brand portfolio; licensing basis not disclosed)Shower Mate and Luvscent are listed at Walmart US. Luvscent entered Japan in 2025. Black Fore and Bicolor are described as premium growth brands.[S35][S10][S12][S39]
Oral care2080 (toothpaste, toothbrushes)Long-standing domestic flagship. Six China-made SKUs were recalled in January 2026: Basic, Daily Care, Smart Care Plus, Classic Care, Triple Effect Alpha Fresh and Triple Effect Alpha Strong. Domestically made 2080 products tested clean.[S21][S22]
Fabric careSpark (스파크, powder detergent); Liq (리큐, gel detergent); Wool Shampoo (울샴푸, neutral detergent); Le Chatelat (르샤트라, fabric softener)Fabric-softener launches drove household growth in 2019.[S38][S39][S50]
Kitchen careTrio (트리오); Soonsaem (순샘)Trio is described by the company as Korea's first dishwashing detergent.[S39][S38]
Hygiene and home careLabsin (랩신); Home Vaccine (홈백신); and other home-care marksLabsin was launched in Q4 2019 and scaled during COVID.[S50][S39]
Other marks in the portfolioDerma & More, Alpist, Chiubi, Salarium, Smalland, Sabor, Herb Mari 1848, Mom's Choice (엄마의선택), Petitee (쁘띠에)Individual revenue not disclosed.[S39]

Brand-level revenue is not publicly disclosed. The only data points available are historical: AGE20's at more than 85% of cosmetics revenue at IPO [S38], and AGE20's at about 90% of cosmetics results in 2019 [S50].

Financial Narrative

All figures are K-IFRS consolidated, KRW, fiscal years ending 31 December. Primary data comes from S&P Global Market Intelligence via StockAnalysis [S1][S2][S3], cross-checked against Hana Securities [S5] and finanzen.at [S6].

Income statement

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Revenue by Segment and Segment Margins & Growth (%)

MetricFY2023FY2024FY2025

Cosmetics revenue (KRW Bn)

251.2261.5214.9

Household goods revenue (KRW Bn)

418.0417.6428.5

Other and eliminations (KRW Bn, derived)

-0.30.011.1

Consolidated revenue (KRW Bn)

668.9679.1654.5

Cosmetics operating profit (KRW Bn)

36.429.17.4

Household goods operating profit (KRW Bn)

25.618.313.7

Cosmetics operating margin (%)

14.511.13.4

Household goods operating margin (%)

6.14.43.2

Cosmetics share of consolidated revenue (%)

37.638.532.8

Household share of consolidated revenue (%)

62.561.565.5

Segment Revenue

Metric1Q252Q253Q254Q251Q262Q26

Consolidated revenue (KRW Bn)

151.1171.3169.3162.9158.8194.2

Cosmetics revenue (KRW Bn)

45.962.551.555.051.975.3

Cosmetics – domestic (KRW Bn)

22.021.919.123.119.721.1

Cosmetics – overseas (KRW Bn)

23.940.632.431.932.254.2

Household revenue (KRW Bn)

104.0105.1114.6104.8103.7115.2

Consolidated operating profit (KRW Bn)

6.011.27.3-3.4-1.64.5

Cosmetics operating profit (KRW Bn)

1.16.82.1-2.6-1.54.1

Household operating profit (KRW Bn)

4.94.15.4-0.70.20.4

Revenue by Segment

MetricFY2021FY2022FY2023FY2024FY2025

Cosmetics gross segment revenue (KRW Bn)

248.3261.1313.7327.3254.0

Household gross segment revenue (KRW Bn)

355.5392.7418.2420.6441.7

Other (KRW Bn)

11.615.915.815.428.6

Consolidation adjustment (KRW Bn)

-41.4-59.3-78.8-84.3-69.8

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Income Statement and Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Revenue (KRW Bn)

573.9610.4668.9679.1654.5

Revenue growth (%)

-2.46.49.61.5-3.6

Gross profit (KRW Bn)

242.7268.4314.7315.5287.2

SG&A (KRW Bn)

218229253269266

Operating income (KRW Bn)

24.439.061.946.821.1

D&A (KRW Bn)

15.215.215.216.117.3

EBITDA = OI + D&A (KRW Bn, derived)

39.654.277.263.038.4

Pre-tax income (KRW Bn, derived from pre-tax margin)

20.422.859.455.819.6

Net income (KRW Bn)

15.716.648.842.615.2

EPS basic (KRW)

579.56631.701,896.851,689.41603.56

EPS diluted (KRW)

579.56631.701,893.501,689.41603.56

Dividend per share (KRW)

200310580580200

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Gross margin (%)

42.344.047.146.543.9

Operating margin (%)

4.36.49.36.93.2

EBITDA margin (%, derived)

6.98.911.59.35.9

Pre-tax margin (%)

3.63.78.98.23.0

Net margin (%)

2.72.77.36.32.3

Balance Sheet and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Total assets (KRW Bn)

431.5482.6482.4499.4497.8

Cash & equivalents (KRW Bn)

106.1120.465.223.361.4

Cash + short-term investments (KRW Bn)

121.8140.4115.655.968.8

Accounts receivable (KRW Bn)

48.051.263.771.757.1

Inventory (KRW Bn)

80.079.078.193.7104.4

Short-term debt incl. current leases (KRW Bn, derived)

2.0724.031.483.057.14

Long-term debt incl. leases (KRW Bn, derived)

1.431.041.030.990.49

Total debt (KRW Bn)

3.5025.072.514.047.63

Net debt (KRW Bn; negative = net cash)

-118.3-115.3-113.1-51.9-61.2

Total equity (KRW Bn)

346.2359.0387.6400.6399.1

Goodwill (KRW Bn)

0.1810.066.016.013.16

Other intangibles (KRW Bn)

6.167.497.486.214.74

Goodwill + intangibles (KRW Bn)

6.3417.5513.4912.217.90

Working capital (KRW Bn)

186.9158.6173.1196.5193.9

Book value per share (KRW)

13,21013,67215,06315,89415,841

Cash Flow and Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Operating cash flow (KRW Bn)

48.333.950.624.841.0

Capital expenditure (KRW Bn)

-17.7-22.2-31.1-12.3-7.9

Free cash flow (KRW Bn)

30.611.719.512.533.1

FCF margin (%)

5.31.92.91.85.1

Dividends paid (KRW Bn)

-5.24-5.24-8.13-14.91-14.61

Share buybacks (KRW Bn)

00-10.01-10.040

Cash acquisitions (KRW Bn)

0-10.8500-10.34

Change in working capital (KRW Bn)

2.4-22.6-20.5-41.60.4

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2021FY2022FY2023FY2024FY2025

ROE (%)

4.54.612.610.63.8

ROA (%)

3.63.410.18.53.1

ROIC (%)

8.311.921.013.76.0

Current ratio (x, derived)

3.492.362.913.083.12

Total debt / equity (x, derived)

0.0100.0700.0060.0100.019

Total liabilities / equity (%)

24.634.424.424.624.7

Net debt / EBITDA (x, derived; negative = net cash)

-2.99-2.13-1.47-0.82-1.59

Interest coverage (x)

65.4145.7100.5143.951.0

Asset turnover (x, derived)

1.331.341.391.381.31

Days sales outstanding (days, derived)

30.530.634.838.531.8

Days inventory outstanding (days, derived)

88.284.380.594.1103.7

Days payables outstanding (days, derived)

48.043.144.243.149.5

Cash conversion cycle (days, derived)

70.771.871.189.586.0

Revenue by Region and Revenue by Region (%)

MetricFY2024FY2025

Cosmetics domestic revenue (KRW Bn)

87.886.1

Cosmetics overseas revenue (KRW Bn)

173.7128.8

Overseas share of cosmetics (%)

66.459.9

Revenue by Region and Revenue by Region (%) (FY2025)

MetricFY2025

Domestic revenue (KRW Bn)

446.9

Export / overseas revenue (KRW Bn)

207.6

Overseas share (%)

31.7

Per-Share Data and Valuation Multiples (x)

MetricFY2021FY2022FY2023FY2024FY2025

Implied year-end share price (KRW, = P/E × EPS per Hana; derived)

18,98120,87918,64513,21813,133

P/E (x, year-end)

31.933.310.18.222.8

P/B (x)

1.41.51.20.80.8

EV/EBITDA (x)

9.78.14.93.96.1

Dividend yield (%)

1.161.623.294.631.54

Capital Markets

MetricAekyung IndustrialBasis / date

P/E (trailing)

16.1x

28 Sep 2026

P/B

0.71–0.75x

Jul–Sep 2026

EV/EBITDA

5.4x

Jul 2026

EV/Sales

0.25x

Jul 2026

Enterprise value

about KRW 167 bn (market cap minus net cash)

Jul 2026

Peer — Amorepacific Corp.

2026E P/E 27.9x; EV/Sales 2026E 2.08x

Feb 2026

Peer — small/mid K-beauty

12-month forward P/E about 5.8–11.4x

Sep 2026

Per-Share Data and Dividends & Capital Returns

MetricFY2021FY2022FY2023FY2024FY2025

DPS (KRW)

200310580580200

Total dividend (KRW Bn)

5.245.248.1314.9114.61

Payout ratio on EPS (%, derived)

34.549.130.634.333.1

Analyst Conclusions

Management guidance and broker expectations

Management: - Cosmetics ≥50% of revenue by 2028 [S19].

  • Q4 2026 peak-season revenue goal of KRW 200 bn [S5].

  • 2027 to combine growth with margin recovery [S5].

Hana (sole published model): - Q3 2026E revenue KRW 186.2 bn (+10%) with an operating loss of KRW 0.6 bn, due to higher overseas household-promotion costs.

  • Q4 2026E revenue KRW 198.2 bn with operating profit of KRW 5.1 bn.

  • FY2026E revenue KRW 737.4 bn (+12.7%), operating profit KRW 7.4 bn (OPM 1.0%), net income KRW 20.3 bn.

  • FY2027E revenue KRW 781.7 bn, operating profit KRW 21.4 bn (OPM 2.7%) [S5].

Consensus: not available [S5].

Bull case

  1. Overseas inflection is real. Overseas cosmetics grew 34.8% and 33.5% in Q1 and Q2 2026, and the overseas share of revenue reached 42% [S5][S14]. If US channels (Walmart, Olive Young USA, Amazon, TikTok Shop) scale, operating leverage on a gross margin of about 44% [S1] could restore high-single-digit margins.

  2. Balance-sheet optionality. Net cash of KRW 117.5 bn [S2] against a market cap of about KRW 296 bn [S5] means roughly 40% of the market value is cash. EV/EBITDA is about 5x [S4].

  3. Strategic sponsor. Taekwang paid about KRW 26,800 per share after the price adjustment (derived: 447.5 bn / 16.67 m shares) [S17] and has stated a long-horizon commitment [S49]. This supports continued investment and possible further capital deployment.

Bear case

  1. Profits may not return. Hana's FY2026 operating profit estimate of KRW 7.4 bn is a fraction of FY2023's KRW 61.9 bn. Marketing is rising everywhere at once and the cost ratio is drifting upward [S5].

  2. Brand-trust damage. The 2080 recall exposed both supplier-control and disclosure failures (12-day late recall plan) [S22][S23], with sanctions pending [S22]. Household goods are the profit backstop, so erosion there would hurt.

  3. Minority-shareholder misalignment. The free float is small and coverage is thin [S4][S5]. The controller acquired at a large premium without a tender offer. Capital allocation may prioritise group objectives over minority returns.

Key catalysts and monitorables (next 12 months)

  • Q3 2026 results (expected November 2026): whether overseas growth holds at +10% or better and the operating loss stays contained [S5].

  • Q4 2026 peak-season revenue against the KRW 200 bn goal [S5].

  • MFDS administrative-sanction decision on 2080, and any prosecution referral [S22].

  • Humidifier-disinfectant remand verdict and the KFTC referral outcome [S28][S29].

  • US channel expansion: number of Walmart doors, Olive Young USA sell-through and signiq traction on Amazon/TikTok [S14][S35].

  • Inventory trajectory (KRW 121.9 bn at June 2026) and working-capital release [S2].

  • Any Taekwang-led capital actions (capital injection, M&A, dividend policy) and progress on Shopping NT synergies [S19].

  • FY2026 DPS decision (early 2027).

Analyst verdict

Aekyung Industrial is now a turnaround-plus-repositioning story owned by a non-specialist strategic buyer. FY2025 marked a cyclical and structural low. Revenue fell to KRW 654.5 bn and operating profit to KRW 21.1 bn. Cosmetics margins collapsed from 14.5% to 3.4% as the China-dependent AGE20's franchise faltered. The 2080 toothpaste recall in January 2026 then exposed weak supply-chain governance at exactly the wrong moment, and cost the seller KRW 22.5 bn in deal value.

Under Taekwang, management has chosen growth over margin. The early evidence is encouraging on the top line: record Q2 2026 revenue of KRW 194.2 bn, overseas share at 42%, a Walmart listing for Kerasys, and Olive Young USA for AGE20's and LUNA. The evidence on profitability is not yet encouraging. Operating margin is near zero on a trailing basis, inventory has risen to KRW 121.9 bn, and the only published model sees FY2026 operating profit of just KRW 7.4 bn.

The valuation reflects this ambivalence. The shares trade at about 0.7x book value and about 5x EV/EBITDA, with net cash covering about 40% of market value. That is a meaningful margin of safety for patient capital. The 50%-cosmetics-by-2028 target is credible only if signiq and ONE THING achieve US traction. That is unproven: the US is still about 5% of overseas sales, and the company spends roughly 0.5% of revenue on R&D in an increasingly innovation-driven category.

Our synthesis: neutral, with positive asymmetry from a low base. The downside appears cushioned by cash, book value and the household franchise. The upside requires evidence that marketing spend converts into durable, non-China revenue at margins comparable to Korean indie peers. The decisive data points are Q4 2026 sell-through and FY2027 margin direction. Legal and regulatory overhangs (MFDS, KFTC, humidifier litigation) are reputational more than financial for the company itself, but remain headline risks.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleTenureBackground

Kim Sang-jun (김상준)

CEO and inside director; sole CEO since March 2026

CEO since 1 Dec 2023; reappointed at the March 2026 AGM

Former Executive Vice President (전무) at the company; described by the group as experienced across strategy, finance and general management. Age and education not disclosed in the sources reviewed.

Chae Dong-seok (채동석)

Former co-CEO / Vice Chairman (owner family of Aekyung Group)

Stepped down at the March 2026 AGM

Second son of Aekyung Group Chair Jang Young-shin

Jung In-chul (정인철)

Non-executive director (기타비상무이사)

Appointed at the March 2026 AGM

Executive VP and head of future business at Taekwang Industrial; recruited by Taekwang in 2025 to lead its Future Business Office

Outside directors (3)

Independent directors

All three replaced in March 2026

Professors of taxation, accounting and marketing.

Major Shareholders

HolderStake

Taekwang Industrial + 2 (consortium SPC with T2 Private Equity and Yuanta Investment)

63.15%

— of which Taekwang Industrial's economic share

about 50% of the 16.67 m-share block (about 31.56% of the company)

Treasury shares

about 4.6%

Foreign investors (aggregate)

1.59% (30 Sep 2026)

Insiders / institutions (aggregator)

0.30% / 0.46%; free float about 8.0 m shares

Competitive Landscape

Peer Comparison FY2025

MetricAekyung IndustrialAmorepacific Corp.LG H&HAPR

Revenue (KRW Bn, FY2025)

654.5

4,250 (Group 4,620)

6,355.5

about 1,520 (implied from OP and margin; derived)

Revenue growth FY2025 (%)

-3.6+9.5-6.7—

Operating profit (KRW Bn)

21.1335.8170.7365.4

Operating margin (%)

3.27.92.724

Beauty-segment note

Cosmetics OP 7.4

Overseas revenue +15%

Beauty segment operating loss of 97.6

High-growth device and skincare model

R&D intensity

about 0.5% (expense line)

———

Peer Comparison FY2025 (Annual)

CompanyMarket cap (KRW Bn)FY2025 revenue (KRW Bn)FY2025 OP margin (%)Valuation note

Aekyung Industrial

295.56553.2

Not rated; FY2025 P/E 22.8x; P/B 0.8x

VT

424.943719.0

12-month forward P/E 6.5x

Clio

211.43295.0

P/E 5.8x

Able C&C

265.92427.4

12-month forward P/E 8.5x

I'm Family SC

137.122412.1

12-month forward P/E 6.5x

Tonymoly

119.92206.5

12-month forward P/E 11.4x

Company Snapshot

$460.6M

Revenue

932

Employees

1954

Founded

Seoul, South Korea

Headquarters

SWOT Analysis

Strengths

  • Net-cash balance sheet. Net cash was KRW 117.5 bn and total debt only KRW 7.3 bn at 30 June 2026 [S2]. This leaves room to fund a marketing-led growth phase without external financing.
  • Breadth of household franchise. Household revenue was KRW 428.5 bn in FY2025 (about 65% of the total) [S5], spread across leading hair, oral, laundry and kitchen brands that have been on the market for decades [S38][S39].
  • Proven ability to scale a hero product. AGE20's Essence Cover Pact lifted cosmetics from about 4% of revenue in 2015 to about 36% by Q3 2017 [S38b]. It took first place in the foundation category on Tmall Global [S38] and ranked second in foundation on Amazon US in 2021 [S60].
  • Owned manufacturing. The Daejeon plant, with powder-detergent capacity of 82,725 tonnes [S39], reduces dependence on scarce ODM capacity at a time of 2026 ODM tightness [S5].
  • Committed strategic owner. Taekwang paid about KRW 447.5 bn (about 2x market value at signing) and frames the deal as a long-term K-beauty platform [S15][S17][S49].
  • Demonstrated overseas momentum in 2026. Q2 2026 revenue was a record KRW 194.2 bn (+13.3%) with a 42% overseas share (+7pp) [S14]. Overseas cosmetics rose 33.5% [S5].

Weaknesses

  • Collapsing profitability. The operating margin fell from 9.3% (FY2023) to 3.2% (FY2025) and 1.0% on a trailing basis to June 2026 [S1]. Hana forecasts FY2026 operating profit of only KRW 7.4 bn [S5].
  • Concentration risk. China is more than 80% of overseas revenue and the US only about 5% [S5]. The cosmetics portfolio depends on one product family [S31b].
  • Low innovation spend. The R&D expense line is about KRW 3.4 bn, or about 0.5% of revenue (FY2025) [S42].
  • Supply-chain quality-control failure. Triclosan was found in 87% of tested imported 2080 lots, and the recall plan was filed 12 days late [S22][S23].
  • Inventory build. Inventory rose from KRW 78.1 bn (FY2023) to KRW 121.9 bn (June 2026) while revenue was flat [S2]. DIO reached 104 days in FY2025 (derived).
  • Thin float and minimal coverage. Free float is about 8 m shares [S4] and consensus is unavailable (N/A) [S5], which limits institutional ownership and price discovery.

Opportunities

  • US mass retail. Kerasys in about 390 Walmart stores and expanding [S35]; AGE20's and LUNA at Olive Young USA [S14].
  • Skincare pivot. Skincare represents larger demand pools in the US and Europe than makeup, and the company is building signiq and ONE THING to address them [S5][S19].
  • China recovery. Vendor restructuring is complete and Chinese revenue has nearly recovered [S5].
  • Group synergies. Taekwang's Shopping NT data home-shopping channel [S19].
  • Margin leverage when marketing normalises. Hana's 2027 forecast has operating profit nearly tripling to KRW 21.4 bn on revenue of KRW 781.7 bn [S5].
  • New regions. Russia/CIS, Central Asia, Brazil and Poland, supported by K-pop-linked marketing [S13][S14].

Threats

  • MFDS has also signalled punitive surcharges for future violations [S22c].
  • Legacy legal risk. The KFTC criminal referral (October 2025) [S29] and the humidifier-disinfectant remand trial [S28]. The financial burden is allocated to Aekyung Group by agreement [S18], but reputational spill-over remains.
  • Competitive intensity from indie brands with faster product cycles and US scale. APR's FY2025 operating margin was about 24% [S41].
  • Japan colour-cosmetics saturation affecting LUNA [S5].
  • Acquirer-level governance risk. Taekwang Industrial faced a special tax audit (November 2025) [S53] and activist conflict [S47]. Press reporting connects the group's acquisitions to former chairman Lee Ho-jin [S47].
  • Marketing efficiency risk. Hana highlights that spending is rising across every region and category simultaneously [S5]. If US traction lags, margins could stay depressed.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
1 Apr 2025Aekyung Group launches sale of its 63.38% stake (Samjong KPMG) [S31]Start of the change-of-control process
29 Apr 2025Q1 2025: revenue KRW 151.1 bn (−10.7%); operating profit KRW 6.0 bn (−63.3%); cosmetics revenue −27.2% [S10]China weakness exposed
30 Apr 2025Hanwha cuts to Hold, target price KRW 15,000 [S43]Last formal rating found
11 Jun 2025Seller reportedly seeks about 150% control premium [S54c]Valuation tension
19–26 Jun 2025LOIs submitted; T2 PE named final bidder; shortlist of 5 [S32]Competitive process (Taekwang vs Anchor PE)
31 Jul 2025Q2 2025: revenue KRW 171.3 bn (−1.3%); operating profit KRW 11.2 bn (−36.1%); AGE20's ranked first in makeup at Cosmoprof Las Vegas [S11][S11b]Continued compression
Sep 2025Taekwang consortium named preferred bidder; MOU [S31]Buyer confirmed
22 Sep 2025signiq launched on Amazon US [S37]First global skincare brand
29 Sep 2025Taekwang CEO's shareholder letter frames the deal as a K-beauty entry [S49]Strategic intent
15–16 Oct 2025AK Holdings board delays final approval [S13b][S20b]Execution risk
20–21 Oct 2025SPA signed: KRW 470 bn for 63.13% at KRW 28,190/share; Taekwang to take about 31.56% [S15][S16]Deal value set at about 2x market price
29 Oct 2025KFTC refers Aekyung Industrial, SK Chemicals and their CEOs to prosecutors [S29]New legal overhang
4 Nov 2025Q3 2025: revenue KRW 169.3 bn (+2.4%); operating profit KRW 7.3 bn (−23.6%) [S12]Household overseas growth offsets cosmetics
13 Nov 2025Tax authorities begin a special audit of acquirer Taekwang Industrial [S53]Acquirer-level risk
Dec 2025Aekyung ST liquidated [S14b]Portfolio clean-up
2 Jan 2026Report that the acquirer will keep the "Aekyung Industrial" name for three years [S33]Brand continuity
6 Jan 2026Voluntary recall of six China-made 2080 toothpaste SKUs (triclosan) [S21]Major brand-safety event
9 Jan 2026MFDS begins its own sampling and on-site inspection [S22b]Regulatory escalation
20 Jan 2026MFDS: triclosan in 754 of 870 lots (87%), up to 0.16%. Company reported distribution volume of 29 m units. Recall plan filed 12 days past the statutory deadline. Administrative sanctions and tighter import rules announced. [S22][S23]Reputational and legal exposure
Feb 2026FY2025 results: revenue KRW 654.5 bn (−3.6%); operating profit KRW 21.1 bn (−54.8%) [S1][S41]Weakest operating result since 2020
9 Feb 2026Press notes APR has overtaken Aekyung, ending the traditional "Big Three" K-beauty ranking [S41]Competitive repositioning
11–24 Feb 2026Some LPs defer commitments; price cut to KRW 447.5 bn; closing moved to 26 Mar [S17][S54]Recall directly reprices the deal
2 Mar 2026Kerasys enters about 390 Walmart stores [S35]US mass-retail entry for hair care
18 Mar 2026Humidifier-disinfectant remand trial begins at Seoul High Court; verdict targeted for July 2026 [S28]Legacy legal risk (retained by Aekyung Group)
25–26 Mar 2026AGM: Taekwang affiliation, CEO change, ≥50% cosmetics target, reorganisation [S18][S19][S20]Strategic reset
Apr 2026All three outside directors replaced [S48b]Governance refresh
8 Apr 2026ONE THING absorption approved [S24]Skincare consolidation
11 May 2026Q1 2026: revenue KRW 158.8 bn (+5.1%); operating loss KRW 1.6 bn (one-offs); net income KRW 13.7 bn [S13]Revenue inflection; profit noise
15 Jun 2026ONE THING merger completed [S24]—
18 Jun 2026Wage agreement signed without dispute [S34]Stability
Jul 2026Remand-trial verdict scheduled; outcome not confirmed in the sources reviewed [S28]Monitor
12 Aug 2026Q2 2026: record revenue KRW 194.2 bn (+13.3%); operating profit KRW 4.5 bn (−59.4%); cosmetics +20.5%; overseas share 42% [S14]Growth-over-margin strategy visible
14 Aug 2026Half-year report (plus amended filing) and major-shareholder change report filed [S44]Disclosure
1 Oct 2026Hana initiates (Not Rated): Q3 2026 forecast of KRW 186.2 bn revenue and KRW 0.6 bn operating loss; margins under pressure [S5]Sell-side view

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

7 charts
Revenue by Segment (FY2023–FY2025): Cosmetics revenue fell from KRW 251.2 Bn in FY2023 to KRW 214.9 Bn in FY2025.
Aekyung Industrial Co., Ltd. — Revenue by Segment (FY2023–FY2025)
Series (KRW Bn)FY2023FY2024FY2025
Cosmetics revenue251.2261.5214.9
Household goods revenue418417.6428.5
Other and eliminations-0.3011.1
Consolidated revenue668.9679.1654.5
Cosmetics operating profit36.429.17.4
Household goods operating profit25.618.313.7

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. S1StockAnalysis.com (data: S&P Global Market Intelligence) — Aekyung Industrial financials overview / income statement (updated Aug 2026) (stockanalysis.com)
  2. S2StockAnalysis.com — Balance sheet (updated Aug 2026) (stockanalysis.com)
  3. S3StockAnalysis.com — Cash flow statement (stockanalysis.com)
  4. S4StockAnalysis.com — Statistics and valuation (Jul 2026) (stockanalysis.com)
  5. S5Hana Securities, "K-Beauty Small/Mid Caps 31" — Aekyung Industrial company note (1 Oct 2026) (file.alphasquare.co.kr)
  6. S6finanzen.at — Aekyung Industrial EPS / DPS history (finanzen.at)
  7. S7Paasa — Aekyung Industrial stock data and FY2021–FY2025 statements (paasa.com)
  8. S8Kukinews (23 Jan 2025) — FY2024 preliminary results (kukinews.com)
  9. S9Toyo Economy (24 Jan 2025) — FY2024 results detail (sateconomy.co.kr)
  10. S10Dealsite (29 Apr 2025) — Q1 2025 results (dealsite.co.kr)
  11. S11Hankyung Magazine (31 Jul 2025) — Q2 2025 results (magazine.hankyung.com)
  12. S11bAju News (31 Jul 2025) — Q2 2025 / Cosmoprof (ajunews.com)
  13. S12Kukinews (4 Nov 2025) — Q3 2025 results (kukinews.com)
  14. S13Herald (12 May 2026) and DDaily (11 May 2026) — Q1 2026 results · ddaily.co.kr
  15. S13bAsia Economy (15 Oct 2025) — AK Holdings board delay (view.asiae.co.kr)
  16. S14Edaily (12 Aug 2026) and InTheNews (12 Aug 2026) — Q2 2026 results · inthenews.co.kr
  17. S14bCB Insights — ONE THING / Aekyung ST liquidation reference (cbinsights.com)
  18. S14cCB Insights — ONE THING acquisition value (USD 10.93 m) (cbinsights.com)
  19. S15Digital Today AI Gongsi — SPA disclosure (21 Oct 2025) (digitaltoday.co.kr)
  20. S16Digital Today AI Gongsi — Taekwang acquisition decision (20 Oct 2025) (digitaltoday.co.kr)
  21. S17Bizhankook (20 Feb 2026) — price cut and closing delay (en.bizhankook.com)
  22. S18Toyo Economy (30 Mar 2026) — closing, board changes (sateconomy.co.kr)
  23. S19Digital Daily (26 Mar 2026) — AGM and 2028 beauty target (ddaily.co.kr)
  24. S20Bizwatch (26 Mar 2026) — cosmetics expansion strategy (news.bizwatch.co.kr)
  25. S20bDealsite (16 Oct 2025) — SPA negotiation (dealsite.co.kr)
  26. S21Korea JoongAng Daily / Financial News (Jan 2026) — voluntary recall · en.fnnews.com
  27. S22Money Today (20 Jan 2026) — MFDS test results (mt.co.kr)
  28. S22bDaily Pharm (9 Jan 2026) — MFDS sampling (dailypharm.com)
  29. S22cNocut News (20 Jan 2026) — MFDS rule tightening (nocutnews.co.kr)
  30. S22dKukinews (21 Jan 2026) — MFDS findings (kukinews.com)
  31. S23SBS Biz (20 Jan 2026) — late recall plan (biz.sbs.co.kr)
  32. S24Kukinews (9 Apr 2026) and Cosinkorea (16 Jun 2026) — ONE THING merger · cosinkorea.com
  33. S25Dealsite (2 Sep 2026) — ONE THING finances / call options (dealsite.co.kr)
  34. S26Dealsite (2023) — first M&A, ONE THING KRW 14 bn (dealsite.co.kr)
  35. S27Kyunghyang / Hankyung (26 Dec 2024) — Supreme Court remand · hankyung.com
  36. S27bThe Fact (16 Jan 2025) — victims count, protests (news.tf.co.kr)
  37. S28Newsis (18 Mar 2026) — remand trial schedule (newsis.com)
  38. S29SBS Biz (29 Oct 2025) — KFTC referral (biz.sbs.co.kr)
  39. S29bDigital Times (2022) — KFTC sanction, Chae Dong-seok (dt.co.kr)
  40. S30Bizhankook (5 Sep 2022) — special tax audit (bizhankook.com)
  41. S30bBizhankook — AJP subsidiary reference (same page) (bizhankook.com)
  42. S31Dealsite (2 Apr 2025, 10 Apr 2025) and Metro Seoul (1 Apr 2025) — sale launch · dealsite.co.kr · metroseoul.co.kr
  43. S31bDealsite (10 Apr 2025) — single-product dependence (dealsite.co.kr)
  44. S32Asia Economy (1 Jul 2025) — shortlist; T2 PE final bidder · view.asiae.co.kr
  45. S33Dealsite (5 Jan 2026) — name retained for 3 years (dealsite.co.kr)
  46. S34Money Today (21 Jun 2026) — wage agreement (mt.co.kr)
  47. S35Sidae Ilbo (9 Mar 2026) — Kerasys at Walmart (sidae.com)
  48. S36KED Global (24 Apr 2024) — Silicon2 MOU (kedglobal.com)
  49. S37Coherent Market Insights (22 Sep 2025) — signiq launch (coherentmarketinsights.com)
  50. S38News Tomato (13 Feb 2018), Bizwatch (22 Mar 2018), iNews24 — IPO · news.bizwatch.co.kr · inews24.com
  51. S38bMoney Today (16 Apr 2018) — No. 2 household goods, AGE20's dependence (mt.co.kr)
  52. S39Aekyung Industrial FY2021 business report (영업보고서) (aekyung.co.kr)
  53. S39bAekyung Industrial sustainability reports (2021, 2023) · aekyung.co.kr
  54. S40Kukinews (27 Nov 2023) — Kim Sang-jun appointment (kukinews.com)
  55. S41Asia Economy (9 Feb 2026) — LG H&H / Amorepacific / APR / Aekyung (view.asiae.co.kr)
  56. S41bDaum / Korea JoongAng (8 Feb 2026) — Amorepacific and LG H&H FY2025 (v.daum.net)
  57. S41cDaum (5 Aug 2025) — export share to Greater China (v.daum.net)
  58. S42Valueline — Aekyung income statement detail (domestic/export; R&D line) (valueline.co.kr)
  59. S43Hanwha Investment & Securities (30 Apr 2025) — company note (stock.pstatic.net)
  60. S44Butler.works — company page (segment mix, treasury ratio, filings list) (butler.works)
  61. S45EMIS — Aekyung Industrial profile (emis.com)
  62. S46Catch.co.kr — recruitment listing (employees Jun 2026) (m.catch.co.kr)
  63. S47Korea Times (7 Apr 2026) — Taekwang expansion (koreatimes.co.kr)
  64. S48Bizhankook — Taekwang financing / valuation estimates (en.bizhankook.com)
  65. S48bBizhankook (3 Apr 2026) — outside directors replaced (bizhankook.com)
  66. S49eToday (29 Sep 2025) — Taekwang CEO shareholder letter (etoday.co.kr)
  67. S50Asia Economy (10 Feb 2020); Dealsite (4 Feb 2021); Aju News (10 Feb 2020) — FY2019 / FY2020 · dealsite.co.kr · ajunews.com
  68. S51Dealsite (11 Jun 2025) — 2024 overseas mix (dealsite.co.kr)
  69. S52Metro Seoul (20 Nov 2025) — 2025 cosmetics by quarter, signiq (metroseoul.co.kr)
  70. S53Kyunghyang (13 Nov 2025) — Taekwang Industrial tax audit (khan.co.kr)
  71. S54Dealsite (24 Feb 2026) — T2 PE first deal; LP structure (dealsite.co.kr)
  72. S54bPreqin — profile (61.13% reference) (preqin.com)
  73. S54cDealsite (11 Jun 2025) — premium sought (dealsite.co.kr)
  74. S55Korea Times (2022) — 2080 Hochi toothpaste (koreatimes.co.kr)
  75. S56Dealsite (1 Feb 2024) — ONE THING and Aekyung ST losses (dealsite.co.kr)
  76. S56bDealsite (19 Apr 2021) — Flow, Sosopul (dealsite.co.kr)
  77. S56cHyundai Motor Securities (Feb 2021) — global peer group (file.alphasquare.co.kr)
  78. S57Albamon (2026) — Cheongyang production postings; HQ address (albamon.com)
  79. S58TheVC — company profile (patents, national R&D, Ottogi partnership) (thevc.kr)
  80. S59Aju News (31 Jul 2025) — AGE20's Cosmoprof ranking (ajunews.com)
  81. S60Asia Economy (2021) / CNC News (12 Aug 2026) — Essence Cover Pact on Amazon; SKU counts · cncnews.co.kr
  82. S60bOwler — headlines (SK Geo Centric mono-material packaging; Songdo R&D site) (owler.com)
  83. S61New Daily (11 Jan 2024) — appellate conviction (newdaily.co.kr)
  84. S62MarketScreener — Amorepacific valuation (Feb 2026) (marketscreener.com)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.